Drug development according to signaling diversities of G protein coupled receptors
-
Chair(s):
Robert Lefkowitz,
Professor,Duke University Medical Center, Durham, The United States of AmericaJinpeng Sun,
Professor,Peking University, Beijing, China -
Session description:
Synthetic nanobodies as angiotensin receptor blockers and β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19
Professor Robert Lefkowitz
Professor, Duke University Medical Center, Durham, The United States of AmericaArrestin, a phospho-pattern reader for GPCR signaling
Professor Jinpeng Sun
Professor, Peking University, Beijing, ChinaOral communication speaker - to be confirmed in 2022.
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Professor Denise Wootten
Monash University, Melbourne, AustraliaAssembly of a GPCR-G Protein Complex
Professor Ka Young Chung
Sungkyunkwan University, Seoul, The Republic Of Korea
Speakers
-
Professor Denise WoottenMonash University, Melbourne, Australia
-
Professor Jinpeng SunProfessor, Peking University, Beijing, China
-
Professor Ka Young ChungSungkyunkwan University, Seoul, The Republic Of Korea
-
Professor Robert LefkowitzProfessor, Duke University Medical Center, Durham, The United States of America
Leave A Comment